US · POCI
Precision Optics Corporation, Inc.
- Sector
- Healthcare · Medical - Instruments & Supplies
- Headquarters
- Gardner, MA 01440
- Website
- poci.com
Price · as of 2025-06-30
$4.26
Market cap 33.04M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $16.52 | +287.79% |
| Intrinsic Value(DCF) | $94.39 | +2,115.73% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $3.90 | $34,773.07 | $0.00 | $0.00 | $57.39 |
| 2012 | $2.91 | $414.40 | $0.00 | $13.72 | $10.19 |
| 2013 | $2.55 | $439.54 | $0.00 | $0.00 | $0.00 |
| 2014 | $2.46 | $356.03 | $0.00 | $0.00 | $0.00 |
| 2015 | $2.70 | $86.58 | $0.00 | $0.00 | $0.00 |
| 2016 | $2.10 | $35.53 | $0.00 | $0.00 | $0.00 |
| 2017 | $1.62 | $128.80 | $0.00 | $0.00 | $3.77 |
| 2018 | $4.05 | $537.66 | $0.01 | $0.00 | $0.00 |
| 2019 | $3.90 | $3,921.47 | $107.00 | $0.00 | $0.00 |
| 2020 | $3.30 | $146.80 | $620.03 | $0.00 | $0.00 |
| 2021 | $5.55 | $392.90 | $253.88 | $0.50 | $0.00 |
| 2022 | $5.76 | $5,379.16 | $289.75 | $0.00 | $0.00 |
| 2023 | $6.21 | $285.64 | $228.01 | $0.44 | $0.00 |
| 2024 | $5.48 | $407.14 | $27.27 | $0.00 | $0.33 |
| 2025 | $4.47 | $16.52 | $0.00 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Precision Optics Corporation, Inc.'s (POCI) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $16.52
- Current price
- $4.26
- AI upside
- +287.79%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$94.39
+2,115.73% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| POCI | Precision Optics Corporat… | $4.26 | 33.04M | +288% | +2,116% | — | — | -5.25 | 2.48 | 1.59 | -5.73 | -7.15 | 9.48 | 17.83% | -29.08% | -30.28% | -51.78% | -43.34% | -31.50% | 0.17 | -24.45 | 1.64 | 0.99 | -0.05 | 7347.00% | -7.00% | 2680.00% | -12.44% | -0.58 | -29.47% | 0.00% | 0.00% | 9.11% | -5.52 | -8.11 | 1.60 | -1.34 |
| HBIO | Harvard Bioscience, Inc. | $0.61 | 27.44M | +5,740% | -46% | — | +242% | -2.88 | 0.56 | 0.38 | -51.62 | -1.16 | -8.67 | 58.18% | -6.60% | -13.18% | -18.19% | -5.77% | -9.40% | 0.70 | -1.94 | 0.82 | 0.35 | -27.40 | 24783.00% | -1614.00% | -11556.00% | -5.11% | 0.03 | -1.69% | 0.00% | 0.00% | 0.00% | -12.25 | -41.74 | 0.81 | -0.92 |
| MIRA | MIRA Pharmaceuticals, Inc… | $1.27 | 53.18M | — | — | — | — | -1.99 | 7.09 | — | -1.59 | — | 7.09 | 0.00% | — | — | -238.90% | 1872.70% | -199.93% | 0.00 | -48.40 | 3.99 | 3.92 | 0.35 | -2154.00% | — | 2269.00% | -35.65% | -7.69 | 1298.69% | 0.00% | 0.00% | 0.00% | -1.59 | -2.30 | — | -9.18 |
| MODD | Modular Medical, Inc. | $0.25 | 15.64M | — | — | — | — | -1.66 | 1.83 | — | -1.09 | — | 1.83 | 0.00% | — | — | -131.58% | -459.49% | -115.69% | 0.05 | — | 10.69 | 10.41 | 0.71 | -3462.00% | — | 1636.00% | -58.31% | -12.43 | -439.34% | 0.00% | 0.00% | 13.57% | -1.00 | -1.04 | — | 2.40 |
| NTRB | Nutriband Inc. | $4.44 | 54.06M | +340% | -57% | — | — | -4.78 | 7.79 | 23.39 | -4.51 | -10.98 | 11.26 | 32.68% | -312.62% | -489.86% | -162.94% | -157.60% | -139.89% | 0.03 | -312.51 | 4.88 | 4.46 | 0.41 | 4348.00% | 262.00% | 3184.00% | -9.43% | -4.71 | -111.17% | 0.00% | 0.00% | 8.03% | -6.87 | -9.73 | 21.47 | 19.59 |
| NXGL | NEXGEL, Inc. | $1.15 | 12.25M | +3,170% | +17,257% | — | — | -5.85 | 3.34 | 2.21 | -6.97 | — | 5.03 | 31.63% | -40.91% | -37.76% | -62.78% | -61.44% | -31.34% | 0.49 | -43.88 | 2.07 | 1.11 | -0.35 | -1071.00% | 11247.00% | 961.00% | -22.44% | -1.57 | -74.51% | 0.00% | 0.00% | 0.00% | -5.69 | -4.69 | 2.33 | 0.07 |
About Precision Optics Corporation, Inc.
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.
- CEO
- Joseph N. Forkey
- Employees
- 83
- Beta
- 0.34
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($94.39 ÷ $4.26) − 1 = +2,115.73% (DCF, example).